Is RZLT Worth Buying in 2026?

Rezolute, Inc. Common Stock (NV)

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Rezolute, Inc. Common Stock (NV) (RZLT) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.32% over 10 days); RSI 57 — healthy momentum range; 3-month momentum positive (+56.6%). Concerns: weak 1-year return of -26.9%. Currently 55.6% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

RZLT is in a confirmed uptrend, trading above both its 50-day ($4.80) and 200-day ($4.38) moving averages. An RSI of 57.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -26.9% compares to +20.5% for SPY (trailed the market by 47.4%). The current 55.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,313 today
vs. S&P 500 (SPY) — same period trailed market by 47.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($4.38)
Above 50-day MA ($4.80)
RSI(14) neutral zone (30–70) — currently 57.0
Positive return (-26.9%)
!Within 10% of period high (−55.6%)
Period Range $5.09
$1.07 $11.46
RSI (14) 57.0
0 · OversoldOverbought · 100

Key Metrics

Price$5.09
Period Return-26.9%
Period High$11.46
Period Low$1.07
Drawdown−55.6%
MA-50$4.80
MA-200$4.38
RSI (14)57.0
Avg Volume (30d)1.4M
vs. SPYtrailed by 47.4%
Return Rank#780 of 999

Trade RZLT

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers